OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
OCTHF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVMRB86
- LEI:
- 2138005SRWT4998BCE35
- Country:
- United Kingdom
- Address:
- PRAMA HOUSE, 267 BANBURY ROAD, OX2 7HT OXFORD
- Website:
- https://www.oxcantech.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Oxford Cannabinoid Technologies Holdings PLC develops cannabinoid-based pharmaceutical therapies for pain management and other conditions in the UK.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-06-06 08:00 |
Regulatory News Service
Cancellation of Listing
|
English | 10.0 KB | |
| 2024-05-31 08:00 |
Regulatory News Service
Updated Shareholder Engagement
|
English | 10.6 KB | |
| 2024-05-17 17:30 |
Delisting Announcement
Updated Shareholder Information
|
English | 22.6 KB | |
| 2024-05-08 08:00 |
Regulatory News Service
Intended Cancellation of Listing
|
English | 32.1 KB | |
| 2024-04-11 12:26 |
Regulatory News Service
Appointment of Phase I Clinical Trial CRO
|
English | 17.3 KB | |
| 2024-04-03 09:00 |
Regulatory News Service
OCT Company Update with Doceo
|
English | 7.4 KB | |
| 2024-03-26 11:56 |
Regulatory News Service
Oxford Cannabinoid Technologies video with Doceo
|
English | 6.9 KB | |
| 2024-03-18 08:00 |
Regulatory News Service
Appointment of Hybridan as Adviser
|
English | 14.2 KB | |
| 2024-02-29 08:02 |
Board/Management Change
Directorate Appointment
|
English | 15.3 KB | |
| 2024-02-29 08:01 |
Board/Management Change
Directorate Changes
|
English | 16.2 KB | |
| 2024-02-29 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.8 KB | |
| 2024-02-28 18:35 |
Declaration of Voting Results & Voting Rights Announcements
TR-1: NOTIFICATION OF MAJOR HOLDINGS
|
English | 65.2 KB | |
| 2024-02-28 18:34 |
Declaration of Voting Results & Voting Rights Announcements
TR-1: NOTIFICATION OF MAJOR HOLDINGS
|
English | 71.7 KB | |
| 2024-02-28 18:34 |
Declaration of Voting Results & Voting Rights Announcements
TR-1: NOTIFICATION OF MAJOR HOLDINGS
|
English | 65.4 KB | |
| 2024-02-26 14:07 |
Transaction in Own Shares
Directors’ Dealings
|
English | 40.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT | |
|
QLife Holding AB | Sweden | QLIFE | |
|
Quantum Genomics | France | ALQGC | |
|
QUIA PHARMA AB | Sweden | QUIA |